Biodesix, Inc. BDSX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$31.96M+20.9% | -$35.27M+17.9% | -$39.54M+9.8% | -$41.08M+7.7% | -$40.42M+14.1% | ||
| $5.63M-2.9% | $5.67M-1.8% | $5.73M+8.1% | $5.82M+26.7% | $5.79M+46.2% | ||
| $4.28M-13.8% | $4.14M-37.6% | $4.33M-32.9% | $4.79M-18.7% | $4.97M-13.3% | ||
| $103K-88.0% | $180K-79.7% | $543K+12.4% | $776K+122% | $859K+101% | ||
| —— | —— | $5.14M— | —— | —— | ||
| $1.45M— | $1.86M— | $2.58M— | —— | —— | ||
| $126K+220% | $130K+291% | $111K+203% | -$51K— | -$105K— | ||
| —— | —— | —— | —— | —— | ||
| $39K-84.0% | $107K-55.0% | $209K+31.4% | $202K— | $243K— | ||
| -$1.11M-822% | -$789K-210% | -$441K-206% | -$180K— | $154K— | ||
| $1.84M— | $258K— | —— | —— | —— | ||
| -$25.62M+38.9% | -$24.05M+50.6% | -$28.15M+50.5% | -$29.94M+40.1% | -$41.94M-33.4% | ||
| $266K-91.3% | $259K-92.0% | $1.01M-81.2% | $1.2M-89.1% | $3.07M-80.2% | ||
| -$410K+87.6% | -$403K+88.3% | -$1.18M+78.7% | -$1.4M+87.4% | -$3.3M+78.9% | ||
| $19K-57.8% | $21K-58.8% | $29K-43.1% | $38K-24.0% | $45K-10.0% | ||
| —— | —— | —— | —— | —— | ||
| -$777K-35.6% | -$817K-83.6% | -$724K-201% | -$683K-116% | -$573K-109% | ||
| $47K+27.0% | $30K-31.8% | $36K-5.3% | $34K-10.5% | $37K-26.0% | ||
| $33.22M-35.5% | $16.42M-68.6% | $14.71M-80.1% | $10.03M-88.3% | $51.54M+59.4% | ||
| —— | —— | —— | —— | $6.11M— | ||
| $6.64M-4.1% | $6.4M-8.9% | $7.27M+39.9% | $7.49M+72.4% | $6.93M+56.1% | ||
| $1.33M-22.3% | $1.3M-47.0% | $1.27M-61.9% | $1.02M-77.4% | $1.71M-64.6% | ||
| -$1.11M-822% | -$789K-210% | -$441K-206% | -$180K— | $154K— | ||
| $1.84M— | $258K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $103K-88.0% | $180K-79.7% | $543K-5.9% | $776K+65.6% | $859K+71.2% | ||
| $144K-38.5% | $144K-31.4% | $171K-6.0% | $207K+23.2% | $234K+53.9% | ||
| —— | —— | —— | —— | —— | ||
| $47K+27.0% | $30K-31.8% | $36K-5.3% | $34K-10.5% | $37K-26.0% | ||
| —— | —— | —— | —— | $656K— | ||
| -$777K-35.6% | -$817K-83.6% | -$724K-115% | -$683K-164% | -$573K-156% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$1.11M-822% | -$789K-210% | -$441K-206% | -$180K— | $154K— | ||
| —— | $1.45M— | $1.07M— | $845K— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $69.25K— | $7K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$25.8M+42.7% | -$24.22M+53.3% | -$29.16M+53.1% | -$31.13M+49.0% | -$45.01M+2.1% | ||
| -$25.8M+42.7% | -$24.22M+53.3% | -$29.16M+53.1% | -$31.13M+49.0% | -$45.01M+2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Biodesix, Inc. generate?
- Biodesix, Inc. (BDSX) generated -$25.6M in operating cash flow over the trailing twelve months.
- What is Biodesix, Inc.'s free cash flow?
- After $266.0K of capital expenditures, Biodesix, Inc.'s free cash flow was -$25.8M over the trailing twelve months, up 42.7% year over year.
- Where does Biodesix, Inc.'s cash flow data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
